Skip to main content

Our Network

An overview of our partners from clinics, patient organizations, and healthcare providers – so you can find the right point of contact and reliable treatment pathways more quickly.

Okuvision Netzwerk

Patient Organizations &Community

Together with PRO RETINA Deutschland e. V., Retina Suisse, and Retina International, we advance education and care. This collaboration increases reach, user-friendliness, and everyday support. Specifically, this means: We link medical content with accessible information resources, support information events and webinars, and promote the exchange of experiences among patients, relatives, and healthcare professionals.
For people with RP, reliable guidance is crucial. Therefore, we closely coordinate content (e.g., on therapy eligibility, application, follow-up examinations, and reimbursement options) with our partners. Additionally, we support peer offerings – such as self-help groups, mentoring, or digital consultation hours – so that information is not only accurate but also accessible and practical for everyday life. The community also provides us with valuable feedback on instructions, accessories, and service processes. This feedback is incorporated into our product maintenance and training materials.

Clinical Partners &Study Centers

Currently, long-term data are being collected in Germany as part of a G-BA evaluation study – at 17 university and specialized clinics. Close collaboration with clinics in Germany and Switzerland strengthens both care and evidence.
Our collaborations include, among others: indication assessment and prescription in specialist practice, standardized training with individual parameter settings, and regular follow-up examinations with defined outcome measures. Study centers support data quality (standardized test procedures, documentation) and continuing education for practice teams.
This structure creates continuous knowledge transfer: Findings from clinical research – for example, on dosage questions, safety, and ease of use – are transferred into clinical practice. Conversely, real-world data from care help refine study hypotheses and drive improvements in application, accessories, and patient information.

Supply &
Sources

The CE-marked system is available in Europe. Use our partner search to find a local partner. If none is available in your area, please contact us directly.
How we integrate the network for you in practice:

  1. Find a specialist practice – suitable ophthalmologists/clinics for diagnosis and indication assessment
  2. Prescription & training – issuance of the prescription, individual device settings, and instruction for safe home use
  3. Device provision – collaboration with specialized providers, including accessories and service
  4. Follow-up & support – scheduled follow-up appointments at the practice, with adjustment of stimulation parameters if needed

Organization & reimbursement – support with compiling documentation and navigating application processes.
Thanks to clear interfaces, patients and healthcare providers always know who is responsible for the next step. This reduces friction, ensures predictability, and keeps the therapy on schedule (weekly, 30 minutes).

Insights into Therapy,Research & Company

The OkuStim® therapy was developed for patients with degenerative retinal diseases such as retinitis pigmentosa. It allows you to slow down the progression of the disease. At the heart of the therapy is the OkuStim® system, which enables you to independently stimulate your retina with weak electrical currents at home.